<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>35(2)</volume><submitter>Weber JA</submitter><pubmed_abstract>Clinical application of CRISPR-Cas9 technology for large deletions of somatic mutations is inefficient, and methods to improve utility suffer from our inability to rapidly assess mono- vs. biallelic deletions. Here we establish a model system for investigating allelic heterogeneity at the single-cell level and identify indel scarring from non-simultaneous nuclease activity at gRNA cut sites as a major barrier to CRISPR-del efficacy both &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. We show that non-simultaneous nuclease activity is partially prevented via restriction of CRISPR-Cas9 expression via inducible adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs). Inducible AAV-based expression of CRISPR-del machinery significantly improved mono- and biallelic deletion frequency &lt;i>in vivo&lt;/i>, </pubmed_abstract><journal>Molecular therapy. Nucleic acids</journal><pagination>102172</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11229411</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity.</pubmed_title><pmcid>PMC11229411</pmcid><pubmed_authors>Carrell EM</pubmed_authors><pubmed_authors>Lang JF</pubmed_authors><pubmed_authors>Davidson BL</pubmed_authors><pubmed_authors>Alameh MG</pubmed_authors><pubmed_authors>Weber JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity.</name><description>Clinical application of CRISPR-Cas9 technology for large deletions of somatic mutations is inefficient, and methods to improve utility suffer from our inability to rapidly assess mono- vs. biallelic deletions. Here we establish a model system for investigating allelic heterogeneity at the single-cell level and identify indel scarring from non-simultaneous nuclease activity at gRNA cut sites as a major barrier to CRISPR-del efficacy both &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. We show that non-simultaneous nuclease activity is partially prevented via restriction of CRISPR-Cas9 expression via inducible adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs). Inducible AAV-based expression of CRISPR-del machinery significantly improved mono- and biallelic deletion frequency &lt;i>in vivo&lt;/i>, </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-04T11:24:19.75Z</modification><creation>2025-04-04T11:24:19.75Z</creation></dates><accession>S-EPMC11229411</accession><cross_references><pubmed>38978694</pubmed><doi>10.1016/j.omtn.2024.102172</doi></cross_references></HashMap>